In a Swedish single blinded, randomized, prospective study compared the topical treatment of Pyoderma in dogs with L-Mesitran and conventional treatments. The L-Mesitran honey treatment has proven to be safe, without side effects and easier to perform. The results suggest that L-Mesitran is an effective treatment option compared with shampooing.

Uppsala, Sweden - In February of this year a single blinded, randomized, prospective study about the efficacy of L-Mesitran ointment in the treatment of Pyoderma in dogs, compared to the use of 3% chlorhexidine shampoo was published online.

The purpose of this study was to evaluate whether L-Mesitran was effective for the treatment of surface pyoderma in dogs.

Pyoderma is a very common skin disease in dogs and should always be considered as a secondary infection to an underlying disease. Surface pyoderma is the most superficial and mild form of pyoderma which is usually treated topically with antibacterial shampoo and/or topical antibiotics.

Use of antibiotics induces a risk of bacteria developing resistance, which is an increasing medical problem. L-Mesitran is a honey based CE-marked wound ointment which has in several studies proved to have a good antibacterial effect and does not pose the risk of inducing resistant microorganisms.

The results of this study show that topical treatment with L-Mesitran has an equally good effect on surface pyoderma in the dog compared with 3% chlorhexidine shampoo. The treatment method has proven to be safe, no side effects could be observed and the owners experienced the treatment easier to perform compared with shampooing.The results suggest that L-Mesitran can be an effective treatment option compared with shampooing.

The study was performed by Zandra Jakobsson of the Swedish University of Agriculture, faculty of Veterinary Medicine and Animal Science, department of Clinical Sciences.

The original Swedish version is published online and can be downloaded via: http://stud.epsilon.slu.se/2224/. You can click here for our English translation.

July 11, 2011